MEDTECH STRASBOURG : revenue, balance sheet and financial ratios
MEDTECH STRASBOURG is a French company
founded 4 years ago,
specialized in the sector Services d'aménagement paysager .
Based in STRASBOURG (67000),
this company of category PME
shows in 2023 a revenue of 609 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - MEDTECH STRASBOURG (SIREN 905036067)
Indicator
2023
2022
Revenue
609 137 €
171 600 €
Net income
44 716 €
-166 129 €
EBITDA
-11 695 €
-166 120 €
Net margin
7.3%
-96.8%
Revenue and income statement
In 2023, MEDTECH STRASBOURG achieves revenue of 609 k€. Vs 2022, growth of +255% (172 k€ -> 609 k€). After deducting consumption (0 €), gross margin stands at 609 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -12 k€, representing -1.9% of revenue. Positive scissor effect: EBITDA margin improves by +94.9 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 45 k€, i.e. 7.3% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2023)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
609 137 €
Gross margin (2023)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
609 137 €
EBITDA (2023)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-11 695 €
EBIT (2023)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-229 256 €
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
44 716 €
EBITDA margin (2023)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
-1.9%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 125%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 903.0 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 2.3% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
124.559%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.334%
Cash flow / Revenue (2023)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
2.308%
Repayment capacity (2023)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
902.982
Solvency indicators evolution MEDTECH STRASBOURG
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
Debt ratio
140.416
124.559
Financial autonomy
38.452
41.334
Repayment capacity
-83.118
902.982
Cash flow / Revenue
-96.812%
2.308%
Sector positioning
Debt ratio
124.562023
2022
2023
Q1: 5.28
Med: 31.0
Q3: 81.69
Watch
In 2023, the debt ratio of MEDTECH STRASBOURG (124.56) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
41.33%2023
2022
2023
Q1: 15.41%
Med: 34.96%
Q3: 53.46%
Good
In 2023, the financial autonomy of MEDTECH STRASBOURG (41.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
902.98 years2023
2022
2023
Q1: 0.0 years
Med: 0.49 years
Q3: 1.75 years
Watch+57 pts over 2 years
In 2023, the repayment capacity of MEDTECH STRASBOURG (902.98) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 886 days. Excellent situation: suppliers finance 886 days of the operating cycle (retail model). WCR is negative (-37 days): operations structurally generate cash.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
-62 759 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
886 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR in days of revenue (2023)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
-37 j
WCR and payment terms evolution MEDTECH STRASBOURG
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2022
2023
Operating WCR
2 061 271 €
-62 759 €
Inventory turnover (days)
3075
0
Customer payment term (days)
460
0
Supplier payment term (days)
1549
886
Positioning of MEDTECH STRASBOURG in its sector
Comparison with sector Services d'aménagement paysager
Valuation estimate
Based on 125 transactions of similar company sales
(all years),
the value of MEDTECH STRASBOURG is estimated at
186 490 €
(range 83 300€ - 311 369€).
The price/revenue ratio is 0.35x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
125 transactions
83k€186k€311k€
186 490 €Range: 83 300€ - 311 369€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
Revenue Multiple30%
609 137 €×0.35x
Estimation214 638 €
110 240€ - 304 607€
Net Income Multiple20%
44 716 €×3.2x
Estimation144 270 €
42 891€ - 321 513€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 125 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Services d'aménagement paysager )
Compare MEDTECH STRASBOURG with other companies in the same sector:
Frequently asked questions about MEDTECH STRASBOURG
What is the revenue of MEDTECH STRASBOURG ?
The revenue of MEDTECH STRASBOURG in 2023 is 609 k€.
Is MEDTECH STRASBOURG profitable?
Yes, MEDTECH STRASBOURG generated a net profit of 45 k€ in 2023.
Where is the headquarters of MEDTECH STRASBOURG ?
The headquarters of MEDTECH STRASBOURG is located in STRASBOURG (67000), in the department Bas-Rhin.
Where to find the tax return of MEDTECH STRASBOURG ?
The tax return of MEDTECH STRASBOURG is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does MEDTECH STRASBOURG operate?
MEDTECH STRASBOURG operates in the sector Services d'aménagement paysager (NAF code 81.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart